Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies
NCT07700563
Antibody Mediated Rejection, BK Virus Nephropathy
View Trial DetailsNCT Number: NCT00374400
The purpose of the protocol is to increase the number of living donor transplants by eliminating immune incompatibilities between donors and recipients through paired donation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Christ Hospital, Cincinnati, Ohio, United States
The purpose of the protocol is to increase the number of living donor transplants by eliminating immune incompatibilities between donors and recipients through paired donation.
To increase the number of patients transplanted by paired donation by establishment of regional paired donation programs.
To develop educational programs for potential living donors and their recipient, as well as the opportunity for transplant professionals to increase acceptance of the PDC to maximize the opportunity for organ donation.
To identify and evaluate ethical and psychological factors that may influence the effects of paired donation on living kidney donation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Cincinnati
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07700563
Antibody Mediated Rejection, BK Virus Nephropathy
View Trial DetailsNCT05456243
Kidney Transplant
Rochester, Minnesota, United States
View Trial DetailsNCT07621835
CMV Reactivation, CMV Specific Immune Response
Córdoba, Spain
View Trial DetailsNCT04969757
Kidney Transplant
Paris, France
View Trial Details